Logo image of ALROC.PA

ROCTOOL (ALROC.PA) Stock Fundamental Analysis

EPA:ALROC - Euronext Paris - Matif - FR0010523167 - Common Stock - Currency: EUR

0.45  +0.04 (+9.76%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALROC. ALROC was compared to 104 industry peers in the Machinery industry. While ALROC seems to be doing ok healthwise, there are quite some concerns on its profitability. ALROC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ALROC has reported negative net income.
In the past year ALROC has reported a negative cash flow from operations.
ALROC had negative earnings in each of the past 5 years.
In the past 5 years ALROC reported 4 times negative operating cash flow.
ALROC.PA Yearly Net Income VS EBIT VS OCF VS FCFALROC.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M -2M -3M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -40.49%, ALROC is doing worse than 90.38% of the companies in the same industry.
The Return On Equity of ALROC (-98.84%) is worse than 87.50% of its industry peers.
Industry RankSector Rank
ROA -40.49%
ROE -98.84%
ROIC N/A
ROA(3y)-6.93%
ROA(5y)-16.19%
ROE(3y)-32.01%
ROE(5y)-47.48%
ROIC(3y)N/A
ROIC(5y)N/A
ALROC.PA Yearly ROA, ROE, ROICALROC.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60

1.3 Margins

ALROC has a better Gross Margin (56.98%) than 81.73% of its industry peers.
ALROC's Gross Margin has been stable in the last couple of years.
ALROC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.92%
GM growth 5Y-1.08%
ALROC.PA Yearly Profit, Operating, Gross MarginsALROC.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

ALROC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALROC has more shares outstanding
ALROC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALROC has a worse debt to assets ratio.
ALROC.PA Yearly Shares OutstandingALROC.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
ALROC.PA Yearly Total Debt VS Total AssetsALROC.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -2.94, we must say that ALROC is in the distress zone and has some risk of bankruptcy.
ALROC's Altman-Z score of -2.94 is on the low side compared to the rest of the industry. ALROC is outperformed by 79.81% of its industry peers.
ALROC has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
ALROC has a Debt to Equity ratio (0.31) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z -2.94
ROIC/WACCN/A
WACC6.18%
ALROC.PA Yearly LT Debt VS Equity VS FCFALROC.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M

2.3 Liquidity

A Current Ratio of 3.29 indicates that ALROC has no problem at all paying its short term obligations.
ALROC's Current ratio of 3.29 is amongst the best of the industry. ALROC outperforms 90.38% of its industry peers.
ALROC has a Quick Ratio of 2.62. This indicates that ALROC is financially healthy and has no problem in meeting its short term obligations.
ALROC's Quick ratio of 2.62 is amongst the best of the industry. ALROC outperforms 94.23% of its industry peers.
Industry RankSector Rank
Current Ratio 3.29
Quick Ratio 2.62
ALROC.PA Yearly Current Assets VS Current LiabilitesALROC.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

1

3. Growth

3.1 Past

ALROC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -499.41%.
Looking at the last year, ALROC shows a very negative growth in Revenue. The Revenue has decreased by -32.93% in the last year.
The Revenue has been growing slightly by 4.55% on average over the past years.
EPS 1Y (TTM)-499.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-17417.65%
Revenue 1Y (TTM)-32.93%
Revenue growth 3Y11.45%
Revenue growth 5Y4.55%
Sales Q2Q%-40.72%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALROC.PA Yearly Revenue VS EstimatesALROC.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
ALROC.PA Yearly EPS VS EstimatesALROC.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -0.2 -0.4 -0.6

0

4. Valuation

4.1 Price/Earnings Ratio

ALROC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALROC.PA Price Earnings VS Forward Price EarningsALROC.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALROC.PA Per share dataALROC.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALROC!.
Industry RankSector Rank
Dividend Yield N/A

ROCTOOL

EPA:ALROC (3/7/2025, 7:00:00 PM)

0.45

+0.04 (+9.76%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.06M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.44
P/FCF N/A
P/OCF N/A
P/B 1.01
P/tB 1.84
EV/EBITDA N/A
EPS(TTM)-0.51
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS1.02
BVpS0.44
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.49%
ROE -98.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.98%
FCFM N/A
ROA(3y)-6.93%
ROA(5y)-16.19%
ROE(3y)-32.01%
ROE(5y)-47.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.92%
GM growth 5Y-1.08%
F-Score3
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 146.77%
Cap/Sales 6.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.29
Quick Ratio 2.62
Altman-Z -2.94
F-Score3
WACC6.18%
ROIC/WACCN/A
Cap/Depr(3y)136.76%
Cap/Depr(5y)105.98%
Cap/Sales(3y)5.06%
Cap/Sales(5y)5.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-499.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-17417.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32.93%
Revenue growth 3Y11.45%
Revenue growth 5Y4.55%
Sales Q2Q%-40.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2832.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.1%
OCF growth 3YN/A
OCF growth 5YN/A